![]() |
JOURNAL TOOLS |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |
Share |

I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
REVIEW PCI HOT TOPICS
Minerva Cardioangiologica 2020 October;68(5):386-92
DOI: 10.23736/S0026-4725.20.05312-8
Copyright © 2020 EDIZIONI MINERVA MEDICA
lingua: Inglese
Myocardial revascularization in chronic coronary syndromes: does viability matter?
Alessandra SCATTEIA 1, Anna BARITUSSIO 2, Chiara BUCCIARELLI-DUCCI 3 ✉
1 Division of Cardiology, Villa dei Fiori Hospital, Acerra, Naples, Italy; 2 Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy; 3 Bristol Heart Institute, NIHR Bristol Biomedical Research Centre, University of Bristol, Bristol, UK
Coronary artery disease (CAD) is the leading cause of death worldwide and improving the prognosis and survival of patients with ischemic heart disease remains a priority of cardiovascular specialists. This article will review the principles of myocardial viability, present the noninvasive imaging tests available to clinicians, as well as critically appraise the latest literature on myocardial viability, coronary revascularization and outcome with a final outlook at studies in the pipelines and future evidence in myocardial viability that will be soon available.
KEY WORDS: Acute coronary syndrome; Coronary artery disease; Myocardium